Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis
- PMID: 8664448
- DOI: 10.1006/cyto.1995.0097
Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis
Abstract
Cells infiltrating the Langerhans' islets of prediabetic NOD females were isolated from 6 weeks to 6 months of age. These cells were assayed at a single-cell level for production of eight different cytokines by intracellular immunofluorescent staining. By in vitro stimulation with PMA and ionomycin for 4 hours the method is enhanced also to detect in vivo preactivated cells. During the early phase of insulitis from 6 to 12 weeks of age, mainly the monokines IL-1 alpha, IL-6, and TNF were detected. After stimulation, also IFN-gamma and low numbers of IL-10 and GM-CSF producing cells could be observed, but no IL-2 or IL-4 was seen. This cytokine pattern correlates with an increasing insulitis, and we suggest that these cytokines are important in attracting inflammatory cells to the islets, and may cause initial beta-cell destruction. During a later phase, between 4 and 6 months, there is a characteristic TH1 cytokine profile with production of IL-2 and IFN-gamma occurring after stimulation, as well as lymphocytes producing TNF, supposedly TNF-beta. During this period IL-10 was very rarely observed, and no IL-4 production could be found throughout the study. This indicates the absence of a TH2 cytokine profile in this lesion. In addition IL-6 production occurs in high frequencies at all ages, also in endocrine islet cells. We interpret this as a stress response caused by the inflammatory lesion. Our findings show that the effector phase in NOD insulitis is TH1 rather than TH2 mediated. We also demonstrate that cytokines, that may cause initial tissue destruction, are produced during the recruitment of inflammatory cells.
Similar articles
-
Monokine-producing cells predominate in the recruitment phase of NOD insulitis while cells producing Th1-type cytokines characterize the effector phase.J Autoimmun. 1997 Apr;10(2):147-55. doi: 10.1006/jaut.1996.0115. J Autoimmun. 1997. PMID: 9185876
-
Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin.Immunology. 1995 Dec;86(4):512-8. Immunology. 1995. PMID: 8567014 Free PMC article.
-
IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.J Immunol. 1995 May 1;154(9):4874-82. J Immunol. 1995. PMID: 7722337
-
[Cytokines and inflammation].Rev Prat. 1993 Mar 1;43(5):547-52. Rev Prat. 1993. PMID: 8341924 Review. French.
-
Mechanisms of pancreatic beta-cell destruction in type I diabetes.Diabetes Care. 1988 Nov-Dec;11 Suppl 1:16-23. Diabetes Care. 1988. PMID: 3069387 Review.
Cited by
-
Disease-protected major histocompatibility complex Ea-transgenic non-obese diabetic (NOD) mice show interleukin-4 production not seen in susceptible Ea-transgenic and non-transgenic NOD mice.Immunology. 1998 Sep;95(1):1-7. doi: 10.1046/j.1365-2567.1998.00580.x. Immunology. 1998. PMID: 9767450 Free PMC article.
-
GAD65 antibody isotypes and epitope recognition during the prediabetic process in siblings of children with type I diabetes.Clin Exp Immunol. 2004 Apr;136(1):120-8. doi: 10.1111/j.1365-2249.2004.02416.x. Clin Exp Immunol. 2004. PMID: 15030523 Free PMC article.
-
Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo.J Immunol. 2004 May 1;172(9):5194-9. doi: 10.4049/jimmunol.172.9.5194. J Immunol. 2004. PMID: 15100256 Free PMC article.
-
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.J Clin Invest. 1997 Nov 1;100(9):2243-53. doi: 10.1172/JCI119762. J Clin Invest. 1997. PMID: 9410902 Free PMC article.
-
Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.Diabetologia. 2003 Aug;46(8):1106-14. doi: 10.1007/s00125-003-1164-y. Epub 2003 Jul 10. Diabetologia. 2003. PMID: 12856083
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical